TRICHOLOGY FEATURES OF ALOPECIA IN WOMEN OF REPRODUCTIVE AGE PATIENTS WITH POLYCYSTIC OVARY SYNDROM
Rubrics: OBSTETRICS & GYNAECOLOGY
Authors:
1.
Scientific Centre for Family Health and Human Reproduction Problems
(Laboratory of Physiology and Pathology of Endocrine System, Senior Research Officer)
Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
2.
Irkutsk, Irkutsk region, Russian Federation
3.
Scientific Centre for Family Health and Human Reproduction Problems
(Laboratory of Physiology and Pathology of Endocrine System, Junior Research Officer)
Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
4.
Nauchnyy centr problem zdorov'ya sem'i i reprodukcii cheloveka
(laboratoriya fiziologii i patologii endokrinnoy sistemy, ispolnyayuschaya obyazannosti mladshego nauchnogo sotrudnika)
Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
5.
Nauchnyy centr problem zdorov'ya sem'i i reprodukcii cheloveka
(laboratoriya fiziologii i patologii endokrinnoy sistemy, zaveduyuschiy)
Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
Type:
Article
Pages:
from 9
to 14
Status:
Published
Received:
18.12.2017
Accepted:
18.01.2018
Published:
18.01.2018
Subject area:
UDK 61 Медицина. Охрана здоровья
Language:
Russian, English
Keywords:
alopecia, androgenetic alopecia, dermatoscopy, patterned hair loss, polycystic ovary syndrome
Abstract (English):
Background. Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 5–10 % of reproductive-aged women. The dermatologic manifestations of PCOS play a significant role in diagnosis. The purpose of the present study was to examine the impact of androgenic alopecia among patients with PCOS and to define their most significant trichological features. Because the data on dermatologic changes associated with PCOS are rather scarce, the present study was designed to determine the incidence and prevalence of androgenic alopecia. Materials and methods. We conducted a prospective observational study of patients with PCOS. The diagnosis of PCOS was made according to the consensus criteria adopted in May 2003 in Rotterdam. Each patient signed informed consent, and then a general physical examination, systemic examination, breast and pelvic examination, as well as a detailed trichological examination were carried out. Results. Twenty women with PCOS participated in the study. The median age was 28.7 ± 6.2 years. Oligo/anovulation frequency was 63.2 %, hirsutism frequency – 68.4 %. In our study, the prevalence of androgenic alopecia was found to be 30 %, telogenic hair loss – 55 %, absence of alopecia signs in 15 % of cases. Conclusions. Androgenic alopecia is a prevalent but unreliable marker of biochemical hyperandrogenism. It is therefore imperative for the treating physicians to understand the adverse effects associated with PCOS, recognize these potential health risks in patients, and treat them accordingly.
Background. Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 5–10 % of reproductive-aged women. The dermatologic manifestations of PCOS play a significant role in diagnosis. The purpose of the present study was to examine the impact of androgenic alopecia among patients with PCOS and to define their most significant trichological features. Because the data on dermatologic changes associated with PCOS are rather scarce, the present study was designed to determine the incidence and prevalence of androgenic alopecia. Materials and methods. We conducted a prospective observational study of patients with PCOS. The diagnosis of PCOS was made according to the consensus criteria adopted in May 2003 in Rotterdam. Each patient signed informed consent, and then a general physical examination, systemic examination, breast and pelvic examination, as well as a detailed trichological examination were carried out. Results. Twenty women with PCOS participated in the study. The median age was 28.7 ± 6.2 years. Oligo/anovulation frequency was 63.2 %, hirsutism frequency – 68.4 %. In our study, the prevalence of androgenic alopecia was found to be 30 %, telogenic hair loss – 55 %, absence of alopecia signs in 15 % of cases. Conclusions. Androgenic alopecia is a prevalent but unreliable marker of biochemical hyperandrogenism. It is therefore imperative for the treating physicians to understand the adverse effects associated with PCOS, recognize these potential health risks in patients, and treat them accordingly.
Keywords:
alopecia, androgenetic alopecia, dermatoscopy, patterned hair loss, polycystic ovary syndrome
alopecia, androgenetic alopecia, dermatoscopy, patterned hair loss, polycystic ovary syndrome
1. Spislit trihologicheskie osobennosti
